Pharmaceuticals News and Research

RSS

Aceto third-quarter net sales up 24.5% to $99.3 million

Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced results of operations for its fiscal 2010 third quarter and nine months ended March 31, 2010.

7 May 2010

ADDF awards $210,300 to Amicus Therapeutics to evaluate PCs for treating Alzheimer's disease

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $210,300 to Amicus Therapeutics (Cranbury, NJ) to evaluate small-molecule, orally delivered pharmacological chaperone compounds as a novel approach for treating Alzheimer's disease.

7 May 2010

SBMC 2010 to focus on systems-biological analysis of processes in mammalian cells

More targeted drug development thanks to systems biology - scientists at the SBMC 2010 in Freiburg explain how this works. Systems biology has finally come of age. Evidence for this is the third Conference on Systems Biology of Mammalian Cells (SBMC), which will take place on June 3-5, 2010 at the Concert Hall Freiburg (Konzerthaus) under the auspices of Prof. Dr. Annette Schavan, German Federal Minister of Education and Research.

7 May 2010

Meda acquires exclusive rights for use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals

Meda has acquired exclusive US, Canadian and Japanese rights for the use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals. As part of the agreement, Meda is taking over full responsibility for development and commercialization of the compound. Flupirtine is currently in phase II development for the patented indication fibromyalgia.

7 May 2010

Merrion Pharmaceuticals increases patent protection for Orazol

Merrion Pharmaceuticals plc, a pharmaceutical development company, today announces that it has been granted a further U.S. Patent, increasing the protection for their lead product, Orazol™.

7 May 2010

AACN hosts NTI conference to discuss emerging trends in patient care

Latest advances in complex medical treatments and delivering safe, patient-centered, cost-effective care will be among the hot topics as thousands of nurses who care for high acuity and critically ill patients and their families convene this month in Washington, D.C.

7 May 2010

Survey reveals low awareness of postherpetic neuralgia amongst Americans

The American Pain Foundation (APF) announced today at the American Pain Society (APS) Annual Meeting the results of a national survey that showed postherpetic neuralgia (PHN), also known as after-shingles pain, continues to be a condition with low awareness amongst Americans, demonstrating a need for health care provider (HCP) intervention.

7 May 2010

New documentary film reveals effective alternative therapies for health problems

Soft Touch Chiropractic and Acupuncture will be hosting the following free movie screenings at their wellness center located at 19474 Rinaldi St. Northridge, CA 91326.

7 May 2010

Natazia tablets receive FDA approval for prevention of pregnancy

Bayer HealthCare Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the prevention of pregnancy.

7 May 2010

The Forum calls upon pharma suppliers, distributors, pharmacies to stop distribution of unapproved drugs

Gary Puckrein, President and CEO of the National Minority Quality Forum (The Forum), recently sent a letter to the CEOs of eight major pharmaceutical suppliers, distributors and pharmacies to educate them on the potential threats posed by unapproved drugs in the United States and to ask that they do their part to protect consumers from the harms that can be caused by these unproven products.

7 May 2010

CDI, iPS Academia Japan announce licensing agreement for seminal iPSC patent portfolio

Cellular Dynamics International, Inc. (CDI), the world's largest producer of cellular tools for drug discovery and safety derived from induced pluripotent stem cells (iPSCs), and iPS Academia Japan, Inc., today announced a nonexclusive licensing agreement for the seminal iPSC patent portfolio arising out of the work of Dr. Shinya Yamanaka, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University.

7 May 2010

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced the presentation of data on its novel resolvins for the treatment of both ocular surface diseases and retinal diseases at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, Florida, being held May 2-6, 2010.

7 May 2010

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

Amira Pharmaceuticals, Inc. announced today that preclinical data from its LPA1 receptor antagonist program has been published in the British Journal of Pharmacology.

7 May 2010

Sun Pharmaceutical subsidiary granted USFDA approval for generic Namenda tablets

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.'s Namenda 5 mg and 10 mg tablets.

7 May 2010

Pfizer presents data on in vivo activity of PF-04523655 siRNA drug candidate at ARVO annual meeting

Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that researchers from Pfizer, Inc. presented data on in vivo activity of PF-04523655 at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, being held May 2-6, 2010 in Fort Lauderdale.

7 May 2010

Genzyme to initiate $2 billion stock buyback

Genzyme Corp. today announced that its Board of Directors has voted to pursue several actions to increase shareholder value. The company will initiate a $2 billion stock buyback, under which $1 billion of stock will be repurchased in the near term and financed with debt. The additional $1 billion of stock will be repurchased during the next 12 months.

7 May 2010

Pharmaceuticals News and Research

Aceto third-quarter net sales up 24.5% to $99.3 million

ADDF awards $210,300 to Amicus Therapeutics to evaluate PCs for treating Alzheimer's disease

SBMC 2010 to focus on systems-biological analysis of processes in mammalian cells

Meda acquires exclusive rights for use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals

Merrion Pharmaceuticals increases patent protection for Orazol

AACN hosts NTI conference to discuss emerging trends in patient care

Survey reveals low awareness of postherpetic neuralgia amongst Americans

New documentary film reveals effective alternative therapies for health problems

Natazia tablets receive FDA approval for prevention of pregnancy

The Forum calls upon pharma suppliers, distributors, pharmacies to stop distribution of unapproved drugs

CDI, iPS Academia Japan announce licensing agreement for seminal iPSC patent portfolio

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

Sun Pharmaceutical subsidiary granted USFDA approval for generic Namenda tablets

Pfizer presents data on in vivo activity of PF-04523655 siRNA drug candidate at ARVO annual meeting

Genzyme to initiate $2 billion stock buyback

ImmunoGen prices common stock public offering at $8.00 per share

WHO publishes comprehensive report on H1N1

FDA approves new oral contraceptive Natazia

Oramed reports Phase 2b non-FDA clinical trial results of ORMD-0801 oral insulin capsule

Free eBook - From lab to market: Accelerate your bioprocessing journey eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence